Addressing Cancer-Related Distress Through Survivorship Care in Community Oncology (NCT07673731) | Clinical Trial Compass
By InvitationNot Applicable
Addressing Cancer-Related Distress Through Survivorship Care in Community Oncology
United States15 participantsStarted 2026-06
Plain-language summary
The goal of this study is to understand whether providing a structured survivorship care visit at the beginning of cancer treatment is associated with changes in distress and quality of life in adults with cancer receiving treatment in a community oncology clinic. The main questions it aims to answer are:
* Is participation in a structured survivorship visit at the start of active treatment associated with changes in psychological distress?
* Is participation in the survivorship visit associated with changes in quality of life?
Participants will:
* Be asked to complete questionnaires about their level of distress and overall quality of life.
* Participate in a single survivorship visit with the clinic's Physician Assistant at the Ellis Medical Oncology Clinic.
* Complete the same questionnaires again approximately two weeks and one month after the survivorship visit.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients must fulfill all the following criteria to be included in the study:
* Age 18 years and older.
* Patients with histologically confirmed malignancy, any stage or type.
* Beginning active therapy (either in oral or IV) for cancer at Ellis Medicine/Roswell Park Medical Oncology.
* A score of ≥4 on the NCCN Distress Thermometer at screening.
* Able and willing to provide written informed consent.
* Ability to read and understand English sufficiently to complete study questionnaires.
Exclusion Criteria:
Patients with one or more of the following criteria will be excluded from the study:
* Under the age of 18 years.
* Patient is unable to provide informed consent.
* Currently receiving ongoing therapy or have had treatment for cancer in the past (i.e., not a new start)
* Significant cognitive impairment that would preclude completion of study questionnaires
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Psychological Distress as Measured by the NCCN Distress Thermometer and Problem List
Timeframe: Baseline, 2 weeks after survivorship visit, and 1 month after survivorship visit